MBX Biosciences, Inc. (MBX)
Score window: May. 30, 2025 to May. 29, 2026
| Date | Form | Sentiment | Urgency | Summary | Open |
|---|---|---|---|---|---|
| Dec. 4, 2025 | CORRESP | Neutral/Informational | Moderate | MBX Biosciences, Inc. has submitted a request to the SEC for the acceleration of the effective date of their registration statement on Form S-3. The company seeks to have the regi… | Read Filing EDGAR |
| Sep. 22, 2025 | CORRESP | Neutral/Informational | Moderate | MBX Biosciences, Inc. has submitted a request to the SEC for the acceleration of the effective date of their registration statement on Form S-1. They are seeking to have the regis… | Read Filing EDGAR |
| Sep. 22, 2025 | CORRESP | Neutral/Informational | Moderate | MBX Biosciences, Inc. has submitted a request for the acceleration of the effective date of their Registration Statement on Form S-1, aiming for it to become effective on Septembe… | Read Filing EDGAR |
| Aug. 13, 2025 | UPLOAD | Neutral/Informational | Low | The SEC correspondence dated August 13, 2025, informs P. Kent Hawryluk, CEO of MBX Biosciences, Inc., that the agency does not intend to review the company's draft registration st… | Read Filing EDGAR |